IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q2 2015 Holdings

Filed 2015-08-14 | 16 holdings | $108.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Abbvie Inc.(ABBV)COM00287Y109$106.2M1,580,00097.9%
ANI Pharmaceuticals Inc(ANIP)COM00182C103$1.9M31,0001.8%
Ariad Pharmaceuticals IncCOM04033A100$106.3K12,850,0000.1%
Quest Diagnostics Inc(DGX)COM74834L100$41.7K575,0000.0%
Medicines CoCOM584688105$39.0K1,361,9000.0%
Aegerion Pharmaceuticals IncCOM00767E102$38.6K2,036,8290.0%
Amgen Inc(AMGN)COM031162100$30.7K200,0000.0%
Merck & Co Inc New(MRK)COM58933Y105$22.8K400,0000.0%
Intra Cellular Therapies Inc(ITCIEUR)COM46116X101$11.5K360,0000.0%
Apricus Biosciences IncCOM03832V109$11.2K6,524,5050.0%
Repros Therapeutics IncCOM NEW76028H209$8.1K1,132,3670.0%
Vivus IncCOM928551100$6.1K2,573,9430.0%
Kindred Biosciences IncCOM494577109$4.7K689,0910.0%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$4.0K2,313,7590.0%
Targacept IncCOM87611R306$1.8K630,0000.0%
Eleven Biotherapeutics Inc.COM286221106$11641,2000.0%